Therapy Areas: Oncology
Anixa secures Canadian patent milestone for ovarian cancer vaccine
1 June 2026 - Biotechnology company Anixa Biosciences Inc (NASDAQ: ANIX) reported on Monday that it has received a Notice of Allowance from the Canadian Intellectual Property Office for a patent cover...
Rallybio and Avenzo Therapeutics announce merger agreement and USD215m financing
1 June 2026 - Clinical-stage biotechnology companies Rallybio Corporation (Nasdaq:RLYB) and Avenzo Therapeutics Inc announced on Monday that they have entered into a definitive merger agreement under ...
IBA launches Cyclone iKure for industrial-scale Astatine-211 production
1 June 2026 - Particle accelerator technology company Ion Beam Applications S.A. (IBA) (Euronext Brussels:IBAB) announced on Monday the launch of Cyclone iKure, a dedicated cyclotron designed for rout...
Circio and GenAssist announce gene therapy research collaboration for muscle diseases and in vivo cell therapy
1 June 2026 - Biotechnology companie Circio Holding ASA (OSE:CRNA) and GenAssist Ltd announced on Monday that they have entered into a research collaboration to develop circVec-enhanced AAV vectors fo...
Avacta reports encouraging early efficacy signals for AVA6000 in salivary gland cancer at ASCO 2026
1 June 2026 - Biopharmaceutical company Avacta Group PLC (AIM: AVCT) announced on Monday that it has presented updated clinical data from its Phase 1a/1b trial of AVA6000, its pre|CISION-enabled form ...
Dizal presents positive NSCLC data for DZD6008 and golidocitinib at ASCO 2026
1 June 2026 - Chinese biopharmaceutical company Dizal (SSE:688192) announced on Saturday the presentation of two studies in non-small cell lung cancer (NSCLC) at the 2026 American Society of Clinical ...